Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.

Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.

Item
http://www.wikidata.org/entity/Q35013113
Potential therapeutic benefit of C1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat modelComplement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaquesIn vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology.Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies.Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica.Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms.Role of the immune system in cardiac tissue damage and repair following myocardial infarction.Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.Role of membrane complement regulators in neuromyelitis optica.Immunization of malaria pre-exposed volunteers with PfSPZ Vaccine elicits long-lived IgM invasion-inhibitory and complement-fixing antibodies.Aquaporin-4 Autoantibodies From Neuromyelitis Optica Spectrum Disorder Patients Induce Complement-Independent Immunopathologies in Mice.
P2860

Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.

Item
http://www.wikidata.org/entity/Q35013113
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inhibitor(s) of the classical ...... odels of neuromyelitis optica.
@ast
Inhibitor(s) of the classical ...... odels of neuromyelitis optica.
@en
type
label
Inhibitor(s) of the classical ...... odels of neuromyelitis optica.
@ast
Inhibitor(s) of the classical ...... odels of neuromyelitis optica.
@en
prefLabel
Inhibitor(s) of the classical ...... odels of neuromyelitis optica.
@ast
Inhibitor(s) of the classical ...... odels of neuromyelitis optica.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Inhibitor(s) of the classical ...... odels of neuromyelitis optica.
@en
P2093
P2860
P304
P31
P356
10.1016/J.MOLIMM.2014.06.003
P433
P478
P50
P577
P698
P932